Thermo Fisher Scientific further expands laboratory plastics production to support COVID-19 testing, therapies, vaccines

September 15, 2020  –  Thermo Fisher Scientific Inc. (Waltham, MA) is investing more than $140 million to further expand its laboratory plastics consumables production to support significant global demand for COVID-19 testing, as well as development and manufacturing of therapies and vaccines.

The company says that the rapid increase in production related to COVID-19 testing, and development and manufacturing of therapies and vaccines, has created historic demand for laboratory plastics, including pipette and automation tips, storage tubes and plates, transfer pipettes, and packaging vials and bottles.

To support these needs, Thermo Fisher is creating more than 1,000 jobs across manufacturing sites globally, increasing automation capabilities, and optimizing warehouse and sterilization capacity to improve supply chain agility.

Among the Thermo Fisher sites currently being expanded are:

  • Rochester, N.Y.
  • Petaluma, Calif.
  • Monterrey and Tijuana, Mexico
  • Joensuu, Finland

Learn More